帕博利珠单抗联合二甲双胍治疗转移性头颈部癌的 II 期可行性研究
A Phase II Feasibility Study Combining Pembrolizumab and Metformin in Patients with Metastatic Head and Neck Cancer.
二甲双胍联合帕博利珠单抗耐受性良好,仅出现轻度胃肠道不良事件,并展现出有前景的活性,值得在随机试验中进一步研究。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:T1rho imaging of head and neck cancer: its association with pathological and immunohistochemical biomarkers in nasopharyngeal carcinoma.
T1rho imaging of head and neck cancer: its association with pathological and immunohistochemical biomarkers in nasopharyngeal carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们的结果显示了 T1rho 成像在头颈部肿瘤中可能的潜在生物学机制。
T1rho成像在癌症影像学中显示出潜在应用价值,但目前关于影响癌症T1rho值的生物学过程研究较少。本研究旨在鼻咽癌(NPC)中探讨T1rho成像定量影像生物标志物与成熟的弥散加权成像(DWI)指标,以及肿瘤-基质、免疫组化(IHC)和TIL(肿瘤浸润淋巴细胞)标志物之间可能存在的关联。
对前瞻性招募的50例患者进行原发NPC治疗前T1rho和DWI成像,获得NPC的平均T1rho值和表观弥散系数(ADC),并通过Pearson相关检验评估其与肿瘤-基质、IHC及TIL标志物的相关性,计算相关系数(R)。
平均T1rho值与胶原性基质/淋巴样基质比例呈负相关(R=-0.314,p=0.03),与Ki-67阳性肿瘤细胞百分比呈正相关(R=0.402,p<0.01);但T1rho值与其他肿瘤-基质、IHC或TIL标志物均无关联(p=0.16–0.98),ADC值与上述任何标志物也均无关联(p=0.07–0.82)。
研究结果揭示了T1rho成像在头颈癌中的潜在生物学机制。T1rho成像与胶原性基质和淋巴样基质的比例呈负相关,与肿瘤细胞增殖呈正相关,而这两者均已知与结局有关,提示T1rho成像在头颈癌影像评估中可能具有重要价值。由于本研究属于样本量较小的初步研究,仍需进一步研究验证这些发现。
T1rho imaging showed potential applications in cancer imaging but little research explored the underlying biological processes that contribute to the T1rho values in cancer. This study aimed to investigate the potential associations between quantitative imaging biomarkers from T1rho imaging and the well-established diffusion weighted imaging (DWI), with tumour-stromal, immunohistochemical (IHC), and tumour-infiltration-lymphocytes (TIL) biomarkers in nasopharyngeal carcinoma (NPC).
Pre-treatment T1rho and DWI imaging of primary NPCs were performed in 50 prospectively recruited patients. The mean T1rho and apparent diffusion coefficient (ADC) of NPC were obtained and correlated with tumour-stromal, IHC, TIL biomarkers using the Pearson Correlation test and the coefficients (R) were calculated.
The mean T1rho values negatively correlated with collagenous stroma-lymphoid stroma (R=-0.314, p = 0.03) and positively correlated with percentage of tumour cells positive for Ki-67 (R = 0.402, p < 0.01), but there were no associations between T1rho values and the other tumour-stromal, IHC or TIL biomarkers (p = 0.16-0.98) or between ADC values and any of these biomarkers (p = 0.07-0.82).
Our results showed the possible underlying biological mechanisms of T1rho imaging in head and neck cancer. T1rho imaging negatively correlated with the ratio of collagenous to lymphoid stroma, and positively correlated with tumour cell proliferation, which are both known to be predictors of outcome, suggesting that T1rho imaging may have a valuable role in head and neck cancer imaging. As this is a preliminary study with small sample size, further studies are encouraged to validate our findings.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。